TrialSignal
Clinical trial intelligence report
The Efficacy and Appropriateness of Ball Blankets on Insomnia in Depression in Outpatient Clinics
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 18, 2026
NCT ID
NCT03730974
Status
UNKNOWN
Phase
Not applicable (interventional study without a defined clinical phase)
Sponsor
University of Aarhus
Executive brief
Investment-Ready Snapshot
The trial, sponsored by the University of Aarhus, aims to validate the use of Protac Ball BlanketsTM in treating insomnia associated with depression. If successful, this could position PBB as a viable alternative to pharmacological treatments, which often have side effects and risks of dependency. The market for insomnia treatments is substantial, with increasing demand for non-pharmacological options. The results could enhance the product's marketability and support its integration into clinical practice, potentially reducing healthcare costs associated with depression-related insomnia. Competitive analysis indicates a growing interest in non-drug therapies, suggesting a favorable environment for PBB's adoption if proven effective.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT03730974
Indication
Insomnia Due to Mental Disorder
Modality
medical device
Target
The study investigates the efficacy of Protac Ball BlanketsTM (PBB) as a non-pharmacological intervention for insomnia in patients with depression, focusing on sleep quality and related symptoms.
Intervention
Protac Ball BlanketTM (7kg Flexible)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.